LRRC15 and COVID-19: We found LRRC15 expression caused an up-regulation of 3 antiviral pathways, IFIT, MX, and OAS, and these antiviral pathways are also up-regulated in primates infected with SARS-CoV-2 [42] and COVID-19 patients [43].